97108305 - PHAGEFINITY

Information

• Trademark
• 97108305

• Source

• Serial Number

  97108305

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 11 - Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying, ventilating, water supply and sanitary purposes
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 04, 2021
  3 years ago

• Transaction Date

  May 30, 2023
  a year ago

• Status Date

  May 29, 2023
  a year ago

• Published for Opposition Date

  August 30, 2022
  2 years ago

• Location Date

  October 25, 2022
  2 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  GAGLIARDI, JEANINE

• Attorney Docket Number

  4040.0013T

  Attorney Name

  Leesa N. Weiss

  Law Office Assigned Location Code

  N20

• Owners

  • Adaptive Phage Therapeutics, Inc.

Case File Statements

• GS0401: custom manufacture of pharmaceuticals in the nature of bacteriophage therapeutics for others
• GS0091: Computer software system comprised of downloadable computer software for identifying precision therapy for treatment of bacterial infections
• GS0051: human, animal, plant and microorganism biological preparations for disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the field of medicine; diagnostic kits comprised of medical diagnostic reagents for testing bacteria sensitivity; diagnostic kits comprising medical diagnostic reagents for testing bacteria sensitivity
• PM0001: PHAGE FINITY
• GS0011: diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising diagnostic reagents for testing bacteria sensitivity, except for medical or veterinary use; human, animal, plant and microorganism biological preparations for use in industry and science, namely, for use in drug development; biological preparations for use in industry and science, namely, for treating bacterial contamination in the fields of farming and food preparation; biological preparations for use in industry and science, namely, for treating bacterial contamination in the industrial and food preparation fields
• GS0111: Refrigerators and freezers for medical storage purposes
• GS0441: medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes, namely, providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; medical consulting services in the field of medical diagnostic and prognostic testing; medical services in the nature of medical analysis services for diagnostic and prognostic testing and treatment purposes; medical services in the nature of providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of a person; medical testing and medical diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays
• GS0421: new product research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and pharmaceuticals; medical laboratory services and scientific laboratory services in the nature of clinical and medical laboratory testing services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom biochemical assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; new product research and development of vaccines and therapeutics; providing temporary use of online non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections; medical research, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; laboratory research services in the field of microbiological laboratory testing of bacteria for research purposes and technical consultation relating thereto; scientific and medical research, in particular, design and development of diagnostic assays; medical laboratory services in the nature of testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine; medical laboratory services in the nature of microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto

Case File Event Statements

• 5/30/2023 - a year ago

  19 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/29/2023 - a year ago

  18 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 4/4/2023 - a year ago

  17 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 4/4/2023 - a year ago

  16 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 4/4/2023 - a year ago

  15 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 4/4/2023 - a year ago

  14 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/4/2023 - a year ago

  13 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 10/25/2022 - 2 years ago

  12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/30/2022 - 2 years ago

  11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/30/2022 - 2 years ago

  10 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/10/2022 - 2 years ago

  9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/26/2022 - 2 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/26/2022 - 2 years ago

  7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 7/26/2022 - 2 years ago

  6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 7/26/2022 - 2 years ago

  5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 7/26/2022 - 2 years ago

  4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 7/20/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/15/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/8/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP